Who’s Going to SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
956 cancer centers, universities & companies and 1,832 presenters at the San Antonio Breast Cancer Symposium (SABCS) 2026, an ~11,000-person, mostly clinical & academic meeting of breast cancer oncologists, researchers and oncology biopharma teams. As of Nov 10, 2026.
| Organization | SABCS 2026 Attendance |
|---|---|
Cancer center in Houston and a major institution for breast cancer research and care. | Session Tue Dec 8 4:30–6:15pm Session Wed Dec 9 7–8:30am Session Wed Dec 9 7–8:30am Talk Wed Dec 9 8:06–8:09am Session Wed Dec 9 noon–1pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Session Wed Dec 9 1–2:15pm Talk Wed Dec 9 2:55–3:20pm Talk Wed Dec 9 4:38–4:46pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Session Thu Dec 10 9:30–10:45am Session Thu Dec 10 noon–1pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Session Thu Dec 10 1–2:15pm Talk Thu Dec 10 1:30–1:45pm Talk Thu Dec 10 3:30–4pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Session Fri Dec 11 7–8:30am Talk Fri Dec 11 8–8:03am Talk Fri Dec 11 8:06–8:09am Talk Fri Dec 11 8:09–8:12am Poster Fri Dec 11 12:30–2pm Poster Fri Dec 11 12:30–2pm Poster Fri Dec 11 12:30–2pm |
Find buyers from organizations at SABCS 2026
Tell us what you sell and we’ll find the people at these organizations most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where is SABCS 2026?
San Antonio Breast Cancer Symposium 2026 runs December 8–11, 2026, at the Henry B. González Convention Center in San Antonio, TX.
What are the SABCS 2026 exhibit hall hours?
The exhibit hall is open Wed, Dec 9, 12:00pm–6:30pm; Thu, Dec 10, 12:00pm–6:30pm; Fri, Dec 11, 12:00pm–3:00pm.
Where is the SABCS 2026 floor plan?
See the organizer’s interactive exhibit hall floor plan. This guide gives each exhibitor’s booth number.
Where is the SABCS 2026 program?
This guide lists every organization on the SABCS 2026 program with its sessions; the full program is on the official website.
How do I register for SABCS 2026?
Fees and registration are on the organizer's registration page.
What is SABCS 2026?
The San Antonio Breast Cancer Symposium, a meeting devoted entirely to breast cancer research and care, held December 8–11, 2026 at the Henry B. González Convention Center in San Antonio, Texas. The organizer expects more than 11,000 physicians, researchers and patient advocates from over 100 countries.
What is in this guide?
Every organization we can place at SABCS 2026: the institutions behind the 2,208 talks and posters in SABCS’s online meeting planner (1,915 of them posters), each under its presenting author’s first institution, with the 123 moderators, discussants, panelists and patient advocates of its sessions; and all 129 exhibitors with their booth numbers — 103 on the main floor and 26 in the Patient Advocate Pavilion. That is 956 organizations in one list, each typed, with a short description; the 7 that have left the floor plan keep their pages, marked as no longer listed. Presenters appear as a count, never by name.
Where does this list come from?
SABCS’s own public sources: its online meeting planner, which lists every session, its presentations and each presenting author’s institution, and its exhibitor directory — each organization’s booth, website, location and the profile it published there. Nothing here requires a login.
How are organizations typed and filtered?
Each organization was placed by what it is: universities, cancer centers and hospitals, the trial groups that run breast cancer studies, government agencies, advocacy groups, societies and media, and the companies — pharma, biotech, diagnostics, medical devices and services. It also gets up to three focus areas: HER2+, HR+ or triple-negative disease, and stages of care such as tumor testing, early detection, surgery, side effects and patient support. A presenting institution’s focus comes from the organizer’s own topic for each of its abstracts; an exhibitor’s from its profile or website, and where a drugmaker’s profile was generic, from the breast cancer medicines it is known for.
How current is it?
Pulled from SABCS’s meeting planner and exhibitor directory on November 10, 2026, late-breaking abstracts included; 122 of the 129 exhibitors had published a profile. SABCS posts the full abstract text on November 23 — this guide never publishes abstract text — and exhibitors can sign up or drop out until the meeting, so the lists may still change.
Why are there no names?
This guide is about which organizations are in the room, not which people. It never publishes a person’s name.
Browse SABCS 2026 by
- Genomic and tumor testing 160
- Hormone receptor-positive breast cancer 157
- Triple-negative breast cancer 99
- Patient and family support 96
- Breast surgery and biopsy 93
- HER2-positive breast cancer 81
- Hereditary risk and genetic testing 64
- AI and data 60
- Clinical trials and research 58
- Metastatic breast cancer 54
- Side effects and supportive care 46
- Screening and early detection 39
- Liquid biopsy and MRD 11
Organizations with their own page
172 organizations — every exhibitor and every organization with 10 or more presentations.
- 10x Genomics
- Abbott
- ABCD: After Breast Cancer Diagnosis
- ACROBiosystems
- Agendia
- Alamo Breast Cancer Foundation
- American Association for Cancer Research (AACR)
- American Society of Clinical Oncology (ASCO)
- Artera
- ARTIDIS
- AstraZeneca
- Astrin Biosciences
- Ataraxis
- Avix Medical
- Bay Area Cancer Connections
- BeOne Medicines
- Bio-Rad Laboratories
- Bio-Techne Diagnostics
- BioNTech
- Biovica
- Boehringer Ingelheim
- BostonGene
- Breast Cancer Resource Center
- Breastcancer.org
- Bright Spot Network
- Bristol Myers Squibb
- Cancer Culture
- CancerNetwork
- Cancerodigest / LeCancer.fr
- Caris Life Sciences
- Celcuity
- ChemoMouthpiece
- City of Hope
- Cleveland Clinic
- Columbia University
- Conexiant
- Cooler Heads
- Corcept Therapeutics
- Cracking Cancer
- Daiichi Sankyo
- Dana-Farber Cancer Institute
- DCIS Understood
- Decera Clinical
- Delphi Diagnostics
- Duke University
- Eli Lilly and Company
- Elucent Medical
- Emory University
- European Institute of Oncology
- Exact Sciences
- For the Breast of Us
- Foundation Medicine
- Fudan University Shanghai Cancer Center
- GE HealthCare
- Gemini Health Partners
- Genentech
- Gilead Sciences
- Global Breast Cancer Conference (GBCC)
- Good Clean Clinical Care
- GRASP (Guiding Researchers & Advocates to Scientific Partnerships)
- Greenwich LifeSciences
- Guardant Health
- Gustave Roussy
- HIS Breast Cancer Awareness
- Hologic
- Inocras
- Instituto D'Or de Pesquisa e Ensino
- iProcess Global Research
- Jazz Pharmaceuticals
- Karolinska Institutet
- King Hussein Cancer Center
- Know Your Lemons Foundation
- KUBTEC
- Lantern Pharma
- LeonaBio
- Leslie's Week
- Living Beyond Breast Cancer
- Lobular Breast Cancer Alliance
- Lone Star Oncology
- Male Breast Cancer Global Alliance
- Mammotome
- Mayo Clinic
- Medical University of South Carolina
- Meet H.E.R.
- Memorial Sloan Kettering Cancer Center
- Menarini Silicon Biosystems
- Menarini-Stemline
- Merck & Co.
- Merit Medical
- METAvivor
- Midi Health
- Moffitt Cancer Center
- MultiplexDX
- My Density Matters
- My Faulty Gene
- My Sister My Friend Breast Cancer Support
- Myriad Genetics
- Myriad Oncology
- Natera
- NeoGenomics
- Northwestern University
- Norton Cancer Institute
- Novartis
- NYU Langone Health
- Olema Oncology
- Oncoclínicas
- Onviv
- Organon
- Parexel
- Paxman
- Personalis
- Pfizer
- Phoenix International Institute of Rebirth
- PhotonMedics
- Piedmont Healthcare
- Pink Fund
- Portamedic
- Prairie Wear
- Predicine
- PreludeDx
- Primum
- Puma Biotechnology
- Quest Diagnostics
- Radialis
- Relay Therapeutics
- Reveal Genomics
- Rigel Pharmaceuticals
- RISE UP for Breast Cancer and Women's Health
- Roswell Park Comprehensive Cancer Center
- Royal College of Surgeons in Ireland (RCSI)
- SAGA Diagnostics
- San Antonio Breast Cancer Symposium (SABCS)
- Sarah Cannon Research Institute
- SimBioSys
- Solv Wellness
- SOMAVAC Medical Solutions
- Stanford University
- Stemtech Medical Devices
- Stronger Than Cancer
- SurvivingBreastCancer.org
- Susan G. Komen
- Tempus
- TerSera Therapeutics
- The Breasties
- The IBC Network Foundation
- The Ohio State University
- The University of Texas MD Anderson Cancer Center
- Translational Research in Oncology (TRIO)
- TRIO-US
- Twisted Pink
- Unite for HER
- University of California, Los Angeles
- University of California, San Francisco
- University of Chicago
- University of North Carolina at Chapel Hill
- University of Pennsylvania
- University of Pittsburgh
- University of Washington
- University of Wisconsin–Madison
- UT Health San Antonio
- UT Southwestern Medical Center
- Vanderbilt University
- Veracyte
- VizMark
- Waiv
- Washington University in St. Louis
- Weill Cornell Medicine
- Well Beyond Breast Cancer
- Wertheim Cancer Institute
- Wonders & Worries
- Yale University
- Zero Gravity
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction